Skip to content

Acute Effect of Interval and Continuous Training of Moderate Intensity on Cardiometabolic Responses of Type 2 Diabetics Hypertensive subjects

Acute Effect of Interval and Continuous Aerobic Training of Moderate Intensity on Blood Glucose, Blood Pressure and Flow-Mediated Dilatation of Type 2 Diabetics Hypertensive subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4j342n
Enrollment
Unknown
Registered
2019-09-18
Start date
2019-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, hypertension

Interventions

Experimental group 1 (moderate-intensity interval training): 18 hypertensive type 2 diabetics of both sexes will perform a moderate-intensity interval training session with a 1: 1 ratio, being 3 minut
Other
G11.427.410.698.277

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade de Pernambuco
Collaborator

Eligibility

Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Subjects of both sexes; aged 40-60 years; with type 2 diabetes; with hypertension on stage one or two; with no history of regular exercise for at least six months; with sedentary habits

Exclusion criteria

Exclusion criteria: Subjects with cardiovascular disease; individuals with comorbidities associated with diabetes; with any other chronic disease; subjects with functional limitations; with joint problems; smokers; who use insulin; who use vasodilatory medications; women who have not reached menopause; women doing hormone replacement

Design outcomes

Primary

MeasureTime frame
Endothelial function will be performed immediately before, 30 and 60 minutes after all interventions by a high resolution doppler-duplex ultrasound (Apogee 3500, SIUI, China).

Secondary

MeasureTime frame
Systolic, diastolic and mean blood pressure will be performed right before, 30 and 60 minutes after all interventions by an automatic device (HEM-7320-LA, Omron, Brazil). ;The measurement of capillary blood glucose will be performed right before, 30 and 60 minutes after each intervention by glycosimeters along with reagent filters (Accu-Check Active, Roche, USA).

Countries

Brazil

Contacts

Public ContactIago Dantas

Universidade Federal de Pernambuco

iagovilelad@gmail.com+55-081-991127615

Outcome results

None listed

Source: REBEC (via WHO ICTRP)